Skip to main content

Articles

Page 56 of 335

  1. Somatic alterations in the cancer genome, some of which are associated with changes in gene expression, have been characterized in multiple studies across diverse cancer types. However, less is known about ger...

    Authors: Bernard Pereira, Emma Labrot, Eric Durand, Joshua M. Korn, Audrey Kauffmann and Catarina D. Campbell
    Citation: BMC Cancer 2022 22:675
  2. A novel device for supine positioning in breast radiotherapy for patients with large or pendulous breasts has been developed and tested in phase II studies. This trial is designed to assess the efficacy of the...

    Authors: Cheryl Duzenli, Elisa K. Chan, Alanah M. Bergman, Sheri Grahame, Joel Singer, Levi Burns and Robert A. Olson
    Citation: BMC Cancer 2022 22:673
  3. 18F -fluorodeoxyglucose (FDG) positron emission tomography (PET) plays an important role in the staging and response assessment of lymphoma patients. Our aim was to explore the predictive relevance of metabolic ....

    Authors: Lutz van Heek, Colin Stuka, Helen Kaul, Horst Müller, Jasmin Mettler, Felicitas Hitz, Christian Baues, Michael Fuchs, Peter Borchmann, Andreas Engert, Markus Dietlein, Conrad-Amadeus Voltin and Carsten Kobe
    Citation: BMC Cancer 2022 22:672
  4. Previous studies reported that emodin extracted from Rheum palmatum L. exerts antiproliferation and antimetastatic effects in a variety of human cancer types. However, the role of emodin in hepatocellular carcino...

    Authors: Binyu Qin, Zhili Zeng, Jianliang Xu, Jing Shangwen, Zeng Jie Ye, Shutang Wang, Yanheng Wu, Gongfeng Peng, Qi Wang, Wenyi Gu and Ying Tang
    Citation: BMC Cancer 2022 22:671
  5. Adjuvant chemotherapy (ACT) plays an important role in improving the survival of stage II-III colorectal cancer (CRC) patients after curative surgery. However, the prognostic role of irregular delay of ACT (ID...

    Authors: Yuanyuan Chen, Mingyue Xu, Qianwen Ye, Jia Xiang, Tianhui Xue, Tao Yang, Long Liu and Bing Yan
    Citation: BMC Cancer 2022 22:670
  6. The bone marrow (BM) is the most common site of dissemination in patients with aggressive, metastatic neuroblastoma (NB). However, the molecular mechanisms underlying the aggressive behavior of NB cells in the...

    Authors: Laura Garcia-Gerique, Marta García, Alícia Garrido-Garcia, Soledad Gómez-González, Montserrat Torrebadell, Estela Prada, Guillem Pascual-Pasto, Oscar Muñoz, Sara Perez-Jaume, Isadora Lemos, Noelia Salvador, Monica Vila-Ubach, Ana Doncel-Requena, Mariona Suñol, Angel M. Carcaboso, Jaume Mora…
    Citation: BMC Cancer 2022 22:669
  7. The concept of the ‘BRCAness’ phenotype implies the properties that some sporadic breast cancers (BC) share with BRCA1/2-mutation carriers with hereditary BC. Breast tumors with BRCAness have deficiencies in homo...

    Authors: Farzaneh Darbeheshti, Sepideh Kadkhoda, Mahsa Keshavarz-Fathi, Sepideh Razi, Afshin Bahramy, Yaser Mansoori and Nima Rezaei
    Citation: BMC Cancer 2022 22:668
  8. In China, liver resection has been proven to be one of the most important strategies for hepatocellular carcinoma patients, but the recurrence rate is high. This study sought to investigate the prognostic valu...

    Authors: Nu Li, Xiaoting Wan, Hong Zhang, Zitian Zhang, Yan Guo and Duo Hong
    Citation: BMC Cancer 2022 22:664
  9. Direct and indirect effects of radiofrequency ablation (RFA) on tumor microenvironment of the liver tumor have been noted, which was reported to be related to a variety of tyrosine protein kinase or cytokineti...

    Authors: An-Na Jiang, Bing Wang, Song Wang, Kun Zhao, Hao Wu, Kun Yan, Wei Wu and Wei Yang
    Citation: BMC Cancer 2022 22:663
  10. Ovarian cancer (OC) is among the deadliest malignancies in women and the lack of appropriate markers for early diagnosis leads to poor prognosis in most cases. Previous studies have shown that KAZN is involved in...

    Authors: Songling Zhu, Hongxia Bao, Meng-Chun Zhang, Huidi Liu, Yao Wang, Caiji Lin, Xingjuan Zhao and Shu-Lin Liu
    Citation: BMC Cancer 2022 22:662
  11. Intratumoral fibrosis was positively correlated with histological grade of renal clear cell carcinoma (ccRCC) and intratumoral inflammation. However, the association of intratumoral fibrosis with the immune in...

    Authors: Songchen Han, Wenbo Yang, Caipeng Qin, Yiqing Du, Mengting Ding, Huaqi Yin and Tao Xu
    Citation: BMC Cancer 2022 22:661
  12. Patients with unresectable recurrent rectal cancer (RRC) or colorectal cancer (CRC) with liver metastases, refractory to at least two lines of traditional systemic therapy, may receive third line intraarterial...

    Authors: Stefano Guadagni, Francesco Masedu, Giammaria Fiorentini, Donatella Sarti, Caterina Fiorentini, Veronica Guadagni, Panagiotis Apostolou, Ioannis Papasotiriou, Panagiotis Parsonidis, Marco Valenti, Enrico Ricevuto, Gemma Bruera, Antonietta R. Farina, Andrew R. Mackay and Marco Clementi
    Citation: BMC Cancer 2022 22:660
  13. To our knowledge, previous studies have not investigated hiccups in patients with cancer with detailed patient-level data with the goal of capturing a broad spectrum of hiccup symptomatology.

    Authors: Christopher J. Ehret, Yahya Almodallal, Jennifer G. Le-Rademacher, Nichole A. Martin, Michael R. Moynagh, Arush Rajotia and Aminah Jatoi
    Citation: BMC Cancer 2022 22:659
  14. To evaluate whether the presence of human papillomavirus (HPV) DNA and p16 might be associated with better prognosis in patients with hypopharyngeal carcinoma (HPC), especially on overall survival (OS) and dis...

    Authors: Jinfeng Shi, Ling Wang, Nan Yao, Le Sun, Wenyu Hu, Xiaotong Li, Yixue Yang, Yusheng Wang, Wei Zhu and Bo Li
    Citation: BMC Cancer 2022 22:658
  15. We aimed to explore the necessity of the external iliac lymph nodes (EIN) along with inguinal nodes (IN) region in clinical target volume (CTV) for rectal carcinomas covering the anal canal region.

    Authors: Rong Zheng, YaZhen Zhang, RunFan Chen, Bingjie Guan, YuPing Lin, BiSi Wang, XiaoBo Li, Pan Chi, XiaoPing Chen and BenHua Xu
    Citation: BMC Cancer 2022 22:657
  16. The effects of diet on the interaction between microbes and host health have been widely studied. However, its effects on the gut microbiota of patients with colorectal cancer (CRC) have not been elucidated. T...

    Authors: Tung Hoang, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Jeeyoo Lee and Aesun Shin
    Citation: BMC Cancer 2022 22:656
  17. Osimertinib—the third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI)—has been widely used as a first-line treatment for patients with metastatic EGFR-mutant non-small cell lung...

    Authors: Soei Gen, Ichidai Tanaka, Masahiro Morise, Junji Koyama, Yuta Kodama, Akira Matsui, Ayako Miyazawa, Tetsunari Hase, Yoshitaka Hibino, Toshihiko Yokoyama, Tomoki Kimura, Norio Yoshida, Mitsuo Sato and Naozumi Hashimoto
    Citation: BMC Cancer 2022 22:654
  18. Tyrosine kinase inhibitors (TKIs), such as sunitinib, are used for cancer treatment, but may also affect platelet count and function with possible hemostatic consequences. Here, we investigated whether patient...

    Authors: Bibian M. E. Tullemans, Sanne L. N. Brouns, Frauke Swieringa, Siamack Sabrkhany, Franchette W. P. J. van den Berkmortel, Natascha A. J. B. Peters, Peter de Bruijn, Stijn L. W. Koolen, Johan W. M. Heemskerk, Maureen J. B. Aarts and Marijke J. E. Kuijpers
    Citation: BMC Cancer 2022 22:653
  19. Integrative medicine is used frequently alongside chemotherapy treatment in pediatric oncology, but little is known about the influence on toxicity. This German, multi-center, open-label, randomized controlled...

    Authors: Georg Seifert, Sarah B. Blakeslee, Gabriele Calaminus, Farid I. Kandil, Andrea Barth, Toralf Bernig, Carl Friedrich Classen, Selim Corbacioglu, Jürgen Föll, Sven Gottschling, Bernd Gruhn, Claudia vom Hoff-Heise, Holger N. Lode, David Martin, Michaela Nathrath, Felix Neunhoeffer…
    Citation: BMC Cancer 2022 22:652
  20. SURECAN (SUrvivors’ Rehabilitation Evaluation after CANcer) is a multi-phase study developing and evaluating an Acceptance and Commitment Therapy (ACT) intervention integrated with exercise and work when highl...

    Authors: Elisavet Moschopoulou, Debbie Brewin, Damien Ridge, Sheila Donovan, Stephanie J. C. Taylor, Liam Bourke, Gail Eva, Imran Khan and Trudie Chalder
    Citation: BMC Cancer 2022 22:651
  21. Neoadjuvant chemoradiation followed by esophagectomy has been established as the first-line treatment for locally advanced esophageal cancer. Postoperative enteral nutrition has been widely used to improve per...

    Authors: Yuqin Cao, Dingpei Han, Su Yang, Yongmei Shi, Shengguang Zhao, Qianwen Jin, Jian Li, Chengqiang Li, Yajie Zhang, Weiyu Shen, Jinxian He, Mingsong Wang, Guangyu Ji, Zhigang Li, Yi He, Qixun Chen…
    Citation: BMC Cancer 2022 22:650
  22. Prognosis for patients recurred rapidly after resection of pancreatic ductal adenocarcinoma (PDAC) was extremely poor. We proposed the concept of postoperative hyper-progression disease (PO-HPD) to define recu...

    Authors: Siyi Zou, Xinjing Wang, Haoda Chen, Jiewei Lin, Chenlei Wen, Qian Zhan, Hao Chen, Xiongxiong Lu, Xiaxing Deng and Baiyong Shen
    Citation: BMC Cancer 2022 22:649
  23. Cancer survivors are able to live much longer today than in the past due to advances in treatment. The promotion of health behaviors is important to address among cancer survivors. Not only can health behavior...

    Authors: Trevin E. Glasgow, Kandace P. McGuire and Bernard F. Fuemmeler
    Citation: BMC Cancer 2022 22:648
  24. Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermo...

    Authors: Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro, Ceu Figueiredo, Erika Ruiz, Maria Alsina, Cristina Molero, Marcelo Garrido, Arnoldo Riquelme, Carmelo Caballero, Eva Lezcano, Juan Manuel O’Connor, Federico Esteso, Judith Farrés, José Manuel Mas…
    Citation: BMC Cancer 2022 22:646
  25. Given the young age of patients with CNS WHO grade 2 and 3 oligodendrogliomas and the relevant risk of neurocognitive, functional, and quality-of-life impairment with the current aggressive standard of care tr...

    Authors: A. Wick, A. Sander, M. Koch, M. Bendszus, S. Combs, T. Haut, A. Dormann, S. Walter, M. Pertz, J. Merkle-Lock, N. Selkrig, R. Limprecht, L. Baumann, M. Kieser, F. Sahm, U. Schlegel…
    Citation: BMC Cancer 2022 22:645
  26. Glioblastoma multiforme (GBM) is one of the most malignant tumors in brain with high morbidity and mortality. Mitophagy plays a significant role in carcinogenesis, metastasis, and invasion. In our study, we ai...

    Authors: Jinghua Wang, Xinqi Qiu, Jiayu Huang, Zewei Zhuo, Hao Chen, Ruijie Zeng, Huihuan Wu, Kehang Guo, Qi Yang, Huiling Ye, Wei Huang and Yujun Luo
    Citation: BMC Cancer 2022 22:644
  27. Hepato-pulmonary metastasis of colorectal cancer (CRC) is a rare disease with poor prognosis. This study aims to establish a highly efficient nomogram model to predict overall survival (OS) and cancer-specific...

    Authors: Shenghe Deng, Zhenxing Jiang, Yinghao Cao, Junnan Gu, Fuwei Mao, Yifan Xue, Le Qin, Ke Liu, Jiliang Wang, Ke Wu and Kailin Cai
    Citation: BMC Cancer 2022 22:643
  28. Glioblastoma (GBM) is the most common primary malignant brain tumor in adults exhibiting infiltration into surrounding tissues, recurrence, and resistance to therapy. GBM infiltration is accomplished by many d...

    Authors: Uchurappa Mala, Tapan Kumar Baral and Kumaravel Somasundaram
    Citation: BMC Cancer 2022 22:642
  29. The systemic inflammatory response resulting from the complex interactions between cancer and the host plays an important role in cancer development. Recently, the lymphocyte-C-reactive protein ratio (LCR), wh...

    Authors: Kozo Miyatani, Shohei Sawata, Masahiro Makinoya, Wataru Miyauchi, Shota Shimizu, Yuji Shishido, Tomoyuki Matsunaga, Manabu Yamamoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Toshimichi Hasegawa, Hiroaki Saito and Yoshiyuki Fujiwara
    Citation: BMC Cancer 2022 22:641
  30. Synchronous multiple primary malignant tumors (sMPMTs) are sometimes diagnosed in patients with malignant lymphoma. We herein investigated the prognostic impact of sMPMT in lymphoma patients and the optimal tr...

    Authors: Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Akihiko Kageyama, Yasushi Omuro and Tatsu Shimoyama
    Citation: BMC Cancer 2022 22:640
  31. Malignant pleural mesothelioma, a tumor arising from the membrane covering the lungs and the inner side of the ribs, is a cancer in which genetic alterations of genes encoding proteins that act on or are part ...

    Authors: Loreley Calvet, Odette Dos-Santos, Emmanuel Spanakis, Véronique Jean-Baptiste, Jean-Christophe Le Bail, Armelle Buzy, Pascal Paul, Christophe Henry, Sandrine Valence, Colette Dib, Jack Pollard, Sukhvinder Sidhu, Jürgen Moll, Laurent Debussche and Iris Valtingojer
    Citation: BMC Cancer 2022 22:639
  32. Numerous studies have revealed that gamma delta (γδ) T cell infiltration plays a crucial regulatory role in hepatocellular carcinoma (HCC) development. Nonetheless, a comprehensive analysis of γδ T cell infilt...

    Authors: Jingrui Wang, Sunbin Ling, Jie Ni and Yafeng Wan
    Citation: BMC Cancer 2022 22:638
  33. Recurrent esophageal cancer is associated with dismal prognosis. There is no consensus about the role of surgical treatments in patients with limited recurrences. This study aimed to evaluate the role of surgi...

    Authors: Ping-Chung Tsai, Hung-Che Chien, Po-Kuei Hsu, Jung-Jyh Hung, Chien-Sheng Huang, Wen-Hu Hsu and Han-Shui Hsu
    Citation: BMC Cancer 2022 22:637
  34. Aberrant methylation of EphA7 has been reported in the process of carcinogenesis but not in cervical cancer. Therefore, an integration study was performed to explore the association between EphA7 hypermethylat...

    Authors: Wenfan Zhang, Huiling Cao, Jinhao Yang, Jing Zhao, Zheng Liang, Xiaodong Kang and Rong Wang
    Citation: BMC Cancer 2022 22:636
  35. The prognosis of Borrmann type III advanced gastric cancer (AGC) is known to vary significantly among patients. This study aimed to determine which differentially expressed genes (DEGs) are directly related to...

    Authors: Yufei Wang, Tianyi Fang, Yimin Wang, Xin Yin, Lei Zhang, Xinghai Zhang, Daoxu Zhang, Yao Zhang, Xibo Wang, Hao Wang and Yingwei Xue
    Citation: BMC Cancer 2022 22:635
  36. Semaphorins have been found to play important roles in multiple malignancy-related processes. However, the role of Semaphorin 4B (SEMA4B) in lung cancer remains unclear. Here, we aimed to explore the biologica...

    Authors: Jun Jiang, Yuan Lu, Fang Zhang, Tao Pan, Zhipei Zhang, Yi Wan, Xinling Ren and Rui Zhang
    Citation: BMC Cancer 2022 22:632
  37. Non-muscle invasive bladder cancer can be controlled by transurethral resection of bladder (TURB), but suffers from frequent recurrences in 60–70% of cases. Although, recurrence interval after TURB influences ...

    Authors: Seung-hwan Jeong, Jang Hee Han, Chang Wook Jeong, Hyeon Hoe Kim, Cheol Kwak, Hyeong Dong Yuk and Ja Hyeon Ku
    Citation: BMC Cancer 2022 22:631
  38. The phase III clinical study of adjuvant liposomal muramyl tripeptide (MTP-PE) in resected high-grade osteosarcoma (OS) documented positive results that have been translated into regulatory approval, supportin...

    Authors: David J. Barnes, Peter Dutton, Øyvind Bruland, Hans Gelderblom, Ade Faleti, Claudia Bühnemann, Annemiek van Maldegem, Hannah Johnson, Lisa Poulton, Sharon Love, Gesa Tiemeier, Els van Beelen, Karin Herbschleb, Caroline Haddon, Lucinda Billingham, Kevin Bradley…
    Citation: BMC Cancer 2022 22:629
  39. Eukaryotic translation elongation factors 1 δ (EEF1D), has garnered much attention with regards to their role in the drug resistance of cancers. In this paper, we investigated the effects and mechanisms of inc...

    Authors: Qia Xu, Yun Liu, Shenyi Wang, Jing Wang, Liwei Liu, Yin Xu and Yide Qin
    Citation: BMC Cancer 2022 22:628
  40. Triple-negative breast cancer (TNBC) constitutes 10–20% of breast cancers and is challenging to treat due to a lack of effective targeted therapies. Previous studies in TNBC cell lines showed in vitro growth i...

    Authors: Nanda Kumar Yellapu, Thuc Ly, Mihaela E. Sardiu, Dong Pei, Danny R. Welch, Jeffery A. Thompson and Devin C. Koestler
    Citation: BMC Cancer 2022 22:627
  41. Current guidelines consider T-DM1 the standard 2nd line therapy for HER2 positive metastatic breast cancer (MBC) patients following trastuzumab (T) + pertuzumab (P) and taxane 1st line treatment. Despite this, th...

    Authors: Claudia Omarini, Federico Piacentini, Isabella Sperduti, Krisida Cerma, Monica Barbolini, Fabio Canino, Cecilia Nasso, Christel Isca, Federica Caggia, Massimo Dominici and Luca Moscetti
    Citation: BMC Cancer 2022 22:623
  42. Cholangiocarcinoma (CHOL) is a malignant tumor that originates in the extrahepatic bile duct and can extend from the hilar region to the lower end of the common bile duct. The prognosis of CHOL patients is par...

    Authors: Huaqiang Zhu, Haini Zhao, Jianlu Wang, Shuchao Zhao, Chaoqun Ma, Dongliang Wang, Hengjun Gao, Faji Yang, Qingqiang Ni, Hongguang Li, Xu Zhou, Chunqing Zhang and Jun Lu
    Citation: BMC Cancer 2022 22:620

Featured videos

View featured videos from across the BMC-series journals